Comments
Loading...
NAYA Biosciences Earnings Estimates, EPS & Revenue | NASDAQ:NAYA | Benzinga
NAYA Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 19
EPS
$-0.420
Quarterly Revenue
$1.43M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$6.23M
Analyze the earnings history of NAYA Biosciences using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NAYA | NAYA Biosciences | -$0.42 | — | — | — | $1.58M | — | — | — | 05/14/2025 | Get Alert |
| NAYA | INVO Bioscience | -$0.64 | — | — | — | $1.38M | — | — | — | 04/15/2025 | Get Alert |
| NAYA | NAYA Biosciences | -$0.70 | — | -$0.42 | — | $974.89K | — | $1.43M | — | 11/19/2024 | Get Alert |
| NAYA | NAYA Biosciences | -$3.06 | — | -$0.62 | — | $315.90K | — | $1.84M | — | 08/14/2024 | Get Alert |
| NAYA | NAYA Biosciences | -$4.00 | — | -$0.42 | — | $348.02K | — | $1.58M | — | 05/15/2024 | Get Alert |
| NAYA | NAYA Biosciences | -$4.60 | — | -$0.64 | — | $278.14K | — | $1.38M | — | 04/16/2024 | Get Alert |
| NAYA | INVO Bioscience | -$4.20 | — | -$0.70 | — | $235.32K | — | $974.89K | — | 11/13/2023 | Get Alert |
| NAYA | INVO Bioscience | -$4.60 | -$4.20 | -$3.06 | 27.14% | $146.13K | $2.96M | $315.90K | -89.33% | 08/14/2023 | Get Alert |
| NAYA | NAYA Biosciences | -$4.60 | — | -$4.00 | — | $162.60K | — | $348.02K | — | 05/15/2023 | Get Alert |
| NAYA | NAYA Biosciences | $0.60 | -$3.80 | -$4.60 | -2105.26% | $3.05M | $260.00K | $278.14K | 6.98% | 04/17/2023 | Get Alert |
| NAYA | NAYA Biosciences | -$4.80 | -$2.60 | -$4.20 | -6153.85% | $218.87K | $500.00K | $235.32K | -52.94% | 11/14/2022 | Get Alert |
| NAYA | NAYA Biosciences | -$3.40 | -$4.80 | -$4.60 | 416.67% | $208.47K | $330.00K | $146.13K | -55.72% | 08/15/2022 | Get Alert |
| NAYA | NAYA Biosciences | -$5.00 | -$5.00 | -$4.60 | 800.00% | $684.52K | $240.00K | $162.60K | -32.25% | 05/16/2022 | Get Alert |
| NAYA | NAYA Biosciences | -$12.00 | -$4.40 | $0.60 | 11363.64% | $196.57K | $210.00K | $3.05M | 1351.43% | 03/31/2022 | Get Alert |
| NAYA | NAYA Biosciences | -$7.20 | -$4.00 | -$4.80 | -2000.00% | $336.07K | $330.00K | $218.87K | -33.67% | 11/15/2021 | Get Alert |
| NAYA | INVO Bioscience | — | -$3.80 | -$3.40 | 1052.63% | — | $410.00K | $208.47K | -49.15% | 08/16/2021 | Get Alert |
| NAYA | NAYA Biosciences | — | -$3.40 | -$5.00 | -4705.88% | — | $590.00K | $684.52K | 16.02% | 05/17/2021 | Get Alert |
| NAYA | NAYA Biosciences | — | -$4.20 | -$12.00 | -18571.43% | — | $440.00K | $196.57K | -55.32% | 03/30/2021 | Get Alert |
| NAYA | NAYA Biosciences | — | — | -$7.20 | — | — | — | $336.07K | — | 11/16/2020 | Get Alert |
NAYA Biosciences (NAYA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | 2023-08-14 | $-3.06 | $-4.20 | 27.1 % |
| Q4 | 2023-04-17 | $-4.60 | $-3.80 | -2105.3 % |
| Q3 | 2022-11-14 | $-4.20 | $-2.60 | -6153.9 % |
| Q2 | 2022-08-15 | $-4.60 | $-4.80 | 416.7 % |
NAYA Biosciences (NAYA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | 2023-08-14 | $315.90K | $2.96M | -89.3 % |
| Q4 | 2023-04-17 | $278.14K | $260.00K | 6.98 % |
| Q3 | 2022-11-14 | $235.32K | $500.00K | -52.9 % |
| Q2 | 2022-08-15 | $146.14K | $330.00K | -55.7 % |
FAQ
When is NAYA Biosciences (NASDAQ:NAYA) reporting earnings?
NAYA Biosciences (NAYA) is scheduled to report earnings on May 14, 2025. The last reported earnings were for reported on November 19, 2024 for Q3.
What were the latest earnings per share (EPS) for NAYA Biosciences (NASDAQ:NAYA)?
The Actual EPS was $-0.42, which missed the estimate of $0.00.
What were NAYA Biosciences’s (NASDAQ:NAYA) revenues?
The Actual Revenue was $1.4M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.